QuantuMDx

About QuantuMDx

QuantuMDx Group is a medical technology company founded in 2008 by Jonathan O'Halloran, Elaine Warburton, and Julian Warburton. The company is headquartered in Newcastle upon Tyne, UK, with additional operations in the United States, Asia, and Africa. The founding vision, inspired by experiences with frontline health workers in South Africa, was to address the need for more accessible, affordable, and reliable medical diagnostics.

The company's core product is the Q-POC™, a handheld, portable PCR system that compresses a molecular diagnostic laboratory into a single device. Designed for point-of-care use in settings like hospitals, clinics, and pharmacies, the battery-operated device delivers sample-to-answer results in approximately 30 minutes. This rapid turnaround enables healthcare professionals to test, diagnose, and decide on treatment in a single consultation. The system uses single-use, sealed cassettes for different tests, which are designed for safety and to eliminate contamination risk. The reagents are lyophilised (freeze-dried), allowing for room-temperature storage and longer shelf life.

QuantuMDx's business model revolves around the sale of its Q-POC™ analysis device and the accompanying disposable testing cassettes. The company's first commercial assay was for SARS-CoV-2, and it has since expanded its test menu to include a multiplex panel for SARS-CoV-2, Flu A/B, and RSV. It plans to continue developing a range of syndromic multiplex assays for various infectious diseases, including tuberculosis and hospital-acquired infections. The company serves healthcare professionals, clinical setting managers, laboratory professionals, and testing providers. A key feature of the platform is its connectivity via 3G, 4G, and Wi-Fi, which enables geotagged pathogen data to be sent to the cloud for real-time disease surveillance and mapping.